Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
6.01
+0.34 (6.00%)
At close: Feb 27, 2026, 4:00 PM EST
6.00
-0.01 (-0.12%)
After-hours: Feb 27, 2026, 4:10 PM EST
IMDX Stock Forecast
Stock Price Forecast
The 2 analysts that cover IMDX stock have a consensus rating of "Strong Buy" and an average price target of $10.5, which forecasts a 74.71% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $12.
Price Target: $10.5 (+74.71%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IMDX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +99.67% | Feb 17, 2026 |
| Needham | Needham | Strong Buy Maintains $4.25 → $9 | Strong Buy | Maintains | $4.25 → $9 | +49.75% | Nov 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | -29.28% | Aug 18, 2025 |
Financial Forecast
Revenue This Year
3.29M
from 1.88M
Increased by 74.91%
Revenue Next Year
3.65M
from 3.29M
Increased by 10.85%
EPS This Year
-1.17
from -4.66
EPS Next Year
-0.86
from -1.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.5M | 5.4M | |
| Avg | 3.3M | 3.6M | |
| Low | 3.1M | 1.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 84.2% | 62.8% | |
| Avg | 74.9% | 10.9% | |
| Low | 66.7% | -67.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.16 | -0.78 | |
| Avg | -1.17 | -0.86 | |
| Low | -1.20 | -0.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.